FDA prepares for generative AI inside medical devices

An FDA discussion paper examines variable outputs, model updates, third-party components, intended users, and device autonomy in medical-device oversight. An AI-ECG systematic review may add evidence to the debate, but the available report provides no usable results yet. The FDA paper is not binding guidance or a product alert, but it signals that adaptive and generative medical-device safety is becoming a major issue.